Answers are grounded in this paper and cite their sources.
This analysis explores the relationship between gestational diabetes and undocumented chronic kidney disease in women, suggesting implications for early diagnosis.
We read with interest the nationwide Clalit cohort study by Levin-Iaina et al., published in JASN,1 showing that a substantial proportion of adults who met laboratory criteria for CKD lacked a documented diagnosis and that undocumented CKD was associated with higher risks of mortality and/or KRT. The observation that undocumented CKD appeared more frequent among younger patients and women is particularly notable.1 Pregnancy-related dysglycemia may offer an additional, clinically actionable lens on this diagnostic gap. Gestational diabetes mellitus identifies women at elevated long-term metabolic risk, including a markedly higher risk of subsequent type 2 diabetes.2 Because many women with prior gestational diabetes do not carry a diabetes diagnosis outside pregnancy, they may be classified within nondiabetic strata in electronic health record–based CKD analyses, despite having a distinct life-course risk profile.3 We therefore wonder whether a history of gestational diabetes could help clarify patterns of CKD underdocumentation in women. Could the authors leverage their existing electronic health record framework to examine CKD documentation and outcomes among women with a prior diagnosis of gestational diabetes mellitus? Specifically, it would be informative to (1) report the prevalence of undocumented CKD among women with previous gestational diabetes compared with age-matched women without gestational diabetes and (2) assess whether the association between undocumented CKD and the primary outcome differs in this subgroup. Because the study already integrates longitudinal laboratory data with diagnosis coding over two decades, this analysis may be feasible without additional data collection. If women with prior gestational diabetes mellitus have a higher burden of undocumented CKD, this would highlight a potentially practical window for intervention: Postpartum follow-up after gestational diabetes is already recommended to monitor future metabolic risk,3 and integrating albuminuria/eGFR-based CKD assessment consistent with Kidney Disease Improving Global Outcomes guidance4 could support earlier recognition, risk counseling, and preconception planning in a population that may otherwise be missed. We applaud the authors for emphasizing the consequences of missed CKD recognition and look forward to their perspective on the potential role of pregnancy-related diabetes in this diagnostic gap.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: